MedTrace Logo

Motion Immune Magnetic Resonance Imaging (MRI)

NCT02302521 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2017-08-11

No results posted yet for this study

Summary

The purpose of this study is to evaluate our recently developed MRI reconstruction strategy for producing artifact-free neuro and abdominal MRI data. The new reconstruction strategies, including 1) REKAM and 2) MUSE, are capable of effectively removing motion-related artifacts resulting from global and local motion during neuro and free-breathing abdominal MRI scans, without modifying the MRI pulse sequences and protocols that are currently used in clinical scans. The study team aims to recruit 60 subjects across multiple challenge patient populations: 10 healthy young adults (age 20-30) and 10 healthy older adults (aged 50-70) for abdominal MRI, as well as 20 tremor dominant PD patients and 20 children (age 4-8) for brain MRI scans. There are no known risks in taking MRIs and a unique code will be assigned to each participant to protect their PHI.

Conditions

Interventions

DEVICE

Multiplex Sensitivity Encoding (MUSE)

It is an algorithm for MRI post-processing/image reconstruction (see reference: Chen).

Sponsors & Collaborators

Principal Investigators

  • Nan-kuei Chen, PhD · Duke University

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-28
Primary Completion
2016-11-26
Completion
2016-11-26
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02302521 on ClinicalTrials.gov